Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded Access Open-Label Study of Abiraterone Acetate in Advanced Prostate Cancer (Post COU-AA-001)
2006-006755-12Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abiraterone in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Primary endpoints: Effectiveness based on PSA progression and objective progression and Safety of abiraterone acetate. Started Jan 2007; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-006755-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006755-12.